Drug Shortage Report for MYLAN-ATAZANAVIR

Last updated on 2020-07-31 History
Report ID 96531
Drug Identification Number 02456877
Brand name MYLAN-ATAZANAVIR
Common or Proper name ATAZANAVIR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ATAZANAVIR
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 60 BT
ATC code J05AE
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-11-01
Actual start date 2019-11-01
Estimated end date 2020-07-28
Actual end date 2020-07-17
Shortage status Resolved
Updated date 2020-07-31
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-10-15 English Compare
v2 2019-10-15 French Compare
v3 2019-10-22 English Compare
v4 2019-10-22 French Compare
v5 2019-10-29 English Compare
v6 2019-10-29 French Compare
v7 2019-11-09 English Compare
v8 2019-11-12 English Compare
v9 2019-11-12 French Compare
v10 2020-05-06 English Compare
v11 2020-05-06 French Compare
v12 2020-06-03 English Compare
v13 2020-06-03 French Compare
v14 2020-06-10 English Compare
v15 2020-06-10 French Compare
v16 2020-06-17 English Compare
v17 2020-06-17 French Compare
v18 2020-06-30 English Compare
v19 2020-06-30 French Compare
v20 2020-07-14 English Compare

Showing 1 to 20 of 23